Product References — Human Serum
Multiple Site Place-of-Care Manufactured Anti-CD19 CAR-T Cells Induce High Remission Rates in B-cell Malignancy Patients
Posted by Adam Awdish on
Pooled Human AB Serum Plasma Derived from Innovative Research was used in the following study: Multiple Site Place-of-Care Manufactured Anti-CD19 CAR-T Cells Induce High Remission Rates in B-cell Malignancy Patients Michael Maschan, Paolo F. Caimi, Jane Reese-Koc, Gabriela Pacheco Sanchez, Ashish A. Sharma, Olga Molostova, Larisa Shelikhova, Dmitriy Pershin, Alexey Stepanov, Yakov Muzalevskii, Vinicius G. Suzart, Folashade Otegbeye, David Wald, Ying Xiong, Darong Wu, Adam Knight, Ibe Oparaocha, Beatrix Ferencz, Andre Roy, Andrew Worden, Winfried Kruger, Michael Kadan, Dina Schneider, Rimas Orentas, Rafick-Pierre Sekaly, Marcos de Lima & Boro Dropulić Nature Communications December 10, 2021 Pediatric B-acute lymphoblastic leukemia...
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
Posted by Adam Awdish on
Pooled Human Serum Off The Clot from Innovative Research was used in the following study: Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU Lorena Vigón, Javier García-Pérez, Sara Rodríguez-Mora, Montserrat Torres, Elena Mateos, María Castillo de la Osa, Miguel Cervero, Rosa Malo De Molina, Cristina Navarro, María Aránzazu Murciano-Antón, Valentín García-Gutiérrez, Vicente Planelles, José Alcamí, Mayte Pérez-Olmeda, Mayte Coiras and María Rosa López-Huertas Frontiers in Immunology September 20, 2021 Clinical symptoms of COVID-19 infection can range anywhere from asymptomatic to severe, even fatal, infections caused by the cytokine storm elicited by...
Cytoprotective IgG Antibodies in Sera from a Subset of Patients with AQP4‑IgG Seropositive Neuromyelitis Optica Spectrum Disorder
Posted by Adam Awdish on
Single Donor Human Complement Serum from Innovative Research was used in the following study: Cytoprotective IgG Antibodies in Sera from a Subset of Patients with AQP4‑IgG Seropositive Neuromyelitis Optica Spectrum Disorder LukmaneeTradtrantip, Michael R. Yeaman & A. S. Verkman Scientific Reports November 9, 2021 Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder that attacks the central nervous system and can cause demyelination in the optic nerve, spinal cord, and brain, and potentially cause further neurological deficits. Over 70% of patients suffering from NMOSD are seropositive for IgG autoantibodies which target extracellular epitopes of astrocyte water channel aquaporin-4 (AQP4),...
- Tags: Human Biological Fluids, Human Serum, Pooled Human Complement Serum, Single Donor Human Complement Serum
Integrated Dielectrophoretic and Impedimetric Biosensor Provides a Template for Universal Biomarker Sensing in Clinical Samples
Posted by Adam Awdish on
Single Donor Human Serum Off The Clot from Innovative Research was used in the following study: Integrated Dielectrophoretic and Impedimetric Biosensor Provides a Template for Universal Biomarker Sensing in Clinical Samples Logeeshan Velmanickam, Vidura Jayasooriya, Dharmakeerthi Nawarathna Electrophoresis January 20, 2021 The use of circulating biomarker tests is common in the screening and diagnosis of various diseases and infections. These tests commonly target biomarkers such as DNA, miRNA, and proteins, however, these different molecules all require different testing procedures and assays which increase the time and costs associated with diagnosis. Miniaturized testing devices have been utilized as a faster...
Two Distinct Genotypes of KPC-2-Producing Klebsiella pneumoniae Isolates from South Korea
Posted by Adam Awdish on
Pooled Human Serum Off The Clot from Innovative Research was used in the following study: Two Distinct Genotypes of KPC-2-Producing Klebsiella pneumoniae Isolates from South Korea Jee Hong Kim, Yun Young Cho, Ji Young Choi, Yu Mi Wi, and Kwan Soo Ko Antibiotics July 26, 2021 In South Korea in 2010, the emergence of carbapenemase-producing Gram-negative bacteria caused serious therapeutic concern and challenges. In particular, Klebsiella pneumoniae, which produces K. pneumoniae carbapenemase (KPC), has proven to be one of the most threatening of these carbapenem resistance determinants in clinical settings. This is because K. pneumoniae is difficult to control...